Another meta-analysis[13] focused on 6 trials comparing LHRH agonist to LHRH antagonist in metastatic and nonmetastatic, locally or not advanced PCa patients, naïve of ADT treatment. Here, GNRH1 is linked to posterior cortical atrophy.